Delivery Order SPE2DB20D3103-SPE2DB24FQ0D0
Award Date
8/23/24
Potential Completion Date
8/26/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,176.20 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets, a medication used for cardiovascular conditions. The award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
This federal contract award, valued at $7,105.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,090.60 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-25 mg tablets. The contract is not designated with any set-aside requirements, indicating open competition. It represents a smaller task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,513.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,103.05, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of July 29, 2024. The contract is not designated as a set-aside and is an open competition award. Amerisourcebergen Drug Corp is the prime contractor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,988.53 firm fixed price delivery order is for the supply of Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through...
This federal contract award, valued at $3,426.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan-HCTZ 100-12.5 mg tablets, a cardiovascular medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,979.18, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. It has a period of performance running through October 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,550.39, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which maintains a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The contract has a firm fixed price of $30,541.60 and a period of performance through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...